Results 101 to 110 of about 236,609 (162)

Intranasal administration with recombinant vaccine PRVXJ-delgE/gI/TK-S induces strong intestinal mucosal immune responses against PDCoV. [PDF]

BMC Vet Res, 2023
Huang B, Huang Y, Deng L, Xu T, Jian Z, Lai S, Ai Y, Zhu L, Xu Z.   +8 more
europepmc   +1 more source

Biogenic silver nanoparticle as an adjuvant in an S1 subunit recombinant vaccine. [PDF]

Braz J Microbiol
de Freitas SB, Neto ACPS, Panagio LA, Collares TV, Seixas FK, Sousa FSS, Hartwig DD.   +6 more
europepmc   +1 more source

Evaluation of the Association of Recombinant Proteins NanH and PknG from Corynebacterium pseudotuberculosis Using Different Adjuvants as a Recombinant Vaccine in Mice. [PDF]

Vaccines (Basel), 2023
Scholl NR, Silva MTO, Barbosa TN, de Pinho RB, Alves MSD, Portela RW, Azevedo VAC, Borsuk S.   +7 more
europepmc   +1 more source

Development of a two-component recombinant vaccine for COVID-19. [PDF]

Front Immunol
Sun YS, Xu F, Zhu HP, Xia Y, Li QM, Luo YY, Lu HJ, Wu BB, Wang Z, Yao PP, Zhou Z.   +10 more
europepmc   +1 more source

Correction: An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: A pilot study. [PDF]

PLoS Negl Trop Dis
PLOS Neglected Tropical Diseases Editors.
europepmc   +1 more source

Immune response of large yellow croaker Larimichthys crocea towards a recombinant vaccine candidate targeting the parasitic ciliate Cryptocaryon irritans. [PDF]

Aquac Int, 2023
Jiang S, Huang X, Li T, Zhang Y, Zhang J.   +4 more
europepmc   +1 more source

Peptide Mapping for Sequence Confirmation of Therapeutic Proteins and Recombinant Vaccine Antigens by High-Resolution Mass Spectrometry: Software Limitations, Pitfalls, and Lessons Learned. [PDF]

Int J Mol Sci
Dobrowolski M, Urbaniak M, Pietrucha T.
europepmc   +1 more source

The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors. [PDF]

Vaccines (Basel), 2023
Esteban-Vazquez A, Steiner M, Castañeda E, Andreu-Vazquez C, Thiussard IJ, Somodevilla A, Gracia-Martínez M, Sánchez-Diaz R, García-Yubero C, Paredes-Romero MB, Munoz-Fernández S.   +10 more
europepmc   +1 more source

Virus-like Particles Produced in Plants: A Promising Platform for Recombinant Vaccine Development. [PDF]

Plants (Basel)
Mardanova ES, Vasyagin EA, Ravin NV.
europepmc   +1 more source

Assessment of the Reversion to Virulence and Protective Efficacy in Pigs Receiving the Live Attenuated Classical Swine Fever Recombinant Vaccine Candidate FlagT4G. [PDF]

Vaccines (Basel)
Ramirez-Medina E, Velazquez-Salinas L, Valladares A, Rai A, Burton L, Sastre L, Silva E, Risatti GR, Ganges L, Borca MV.   +9 more
europepmc   +1 more source